Medical Devices; Neurological Devices; Classification of the Computerized Behavioral Therapy Device for the Treatment of Fibromyalgia Symptoms
The Food and Drug Administration (FDA) is classifying the computerized behavioral therapy device for...
Publisher
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Federal Register
- Region
- USA
- Scope
- Regulatory
- Published
- June 26, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
The Food and Drug Administration (FDA) is classifying the computerized behavioral therapy device for...
Source route
Continue on federalregister.gov
Leave the platform to read the original full article on the publisher site.
Source: Federal Register
Scope: Regulatory
Related coverage
More related coverage
Quarterly Epidemiological Commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia and Clostridioides difficile infection, data up to January to March 2026
Epidemiological analyses of mandatory surveillance data on healthcare associated infections (HCAI);...
Hepatitis B: antenatal screening and selective neonatal immunisation pathway
Guidance on the delivery of antenatal screening and selective neonatal immunisation services for pre...
UK Malaria Expert Advisory Group (UKMEAG)
UKMEAG (formerly the Advisory Committee on Malaria Prevention) provides guidelines for health profes...
Intrathecal antibody test request form
Form E22 for requesting intrathecal antibody tests to be carried out by UK Health Security Agency's...